|
시장보고서
상품코드
1688855
세계의 생명공학 분야 배지, 혈청 및 시약 시장Global Markets for Media, Sera and Reagents in Biotechnology |
||||||
세계의 생명공학 분야 배지, 혈청 및 시약 시장 규모는 2024년 63억 달러로 평가되었습니다. 예측 기간 중 CAGR 8.1%로 성장할 것으로 전망되고, 2029년 말에는 93억 달러에 이를 것으로 예상되고 있습니다.
북미 시장은 2024년 23억 달러를 기록했습니다. 예측 기간 동안 CAGR은 8.4%를 나타낼 것으로 추정되고 2029년 말에는 35억 달러에 달할 것으로 전망됩니다. 유럽 시장은 2024년 18억 달러에 이르렀습니다. CAGR 7.4%로 성장할 것으로 예측되고, 2029년 말에는 25억 달러에 이를 것으로 추정됩니다.
본 보고서에서는 세계의 생명공학 분야 배지, 혈청 및 시약 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회의 분석, 법 규제 환경, 신기술 및 기술 개발의 동향, 시장 규모 추이와 예측, 각종 구분, 지역별 상세 분석, 경쟁 구도, 주요 기업프로파일 등을 정리했습니다.
The global market for media, sera and reagents in biotechnology is expected to grow from $6.3 billion in 2024 and is projected to reach $9.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.1% during the forecast period of 2024 to 2029.
The North American market for media, sera and reagents in biotechnology is expected to grow from $2.3 billion in 2024 and is projected to reach $3.5 billion by the end of 2029, at a CAGR of 8.4% during the forecast period of 2024 to 2029.
The European market for media, sera and reagents in biotechnology is expected to grow from $1.8 billion in 2024 and is projected to reach $2.5 billion by the end of 2029, at a CAGR of 7.4% during the forecast period of 2024 to 2029.
This report highlights current and future market potential for media, sera and reagents in biotechnology. It provides a detailed analysis of the market drivers, restraints and opportunities. The report includes detailed information on emerging technologies, patent analysis, ESG development, investment outlook and deals. The report also covers market projections through 2029 and presents a competitive landscape. The report provides market estimates and forecasts based on product type, end user and region. The market is segmented by product type into reagents, media and sera. The reagents market is segmented into reagents: biological response modifiers, cell dissociation reagents and others (amino acids, antibiotics, etc.). Market analysis in the media segment is divided into specialty and classical media based on composition. The media are divided into powdered and ready-to-use liquid media based on formulation. Based on serum components, media are segmented into serum-free and serum-requiring media. The market for sera is segmented based on the source of serum into fetal bovine serum and other sera, including from animal sources such as goats, porcine, rabbits, etc. By end user, the market is segmented into biopharmaceutical companies, academic research institutes, contract research organizations and others. The report includes profiles of the key companies with detailed information about their business segments, financials, product portfolios and recent developments.
The market is segregated by geographical region into North America, Europe, Asia-Pacific and the Rest of the World. The North American region includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific. For market estimates, data is provided for 2021 and 2022 as the historical years, 2023 as the base year and 2029 as the forecast year.